Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development

Andrew C. Hsieh, Eric J. Small, Charles J. Ryan

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Abstract

Many attempts have been made to derive genetic signatures for progressive prostate cancer for both prognostic and therapeutic purposes. These investigations have resulted in the discovery of many pathways, but the signatures exhibit heterogeneity and restricted reproducibility. A thorough and disciplined analysis of genes with androgen-response elements that are expressed in progressive, castration-resistant prostate cancer is an integral step towards the development of new therapeutic or diagnostic targets. We discuss the effects of bona-fide downstream targets of the androgen receptor on cellular proliferation, evasion of apoptosis, and angiogenesis, and consider the clinical potential of these targets.

Original languageEnglish (US)
Pages (from-to)933-939
Number of pages7
JournalLancet Oncology
Volume8
Issue number10
DOIs
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint Dive into the research topics of 'Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development'. Together they form a unique fingerprint.

Cite this